Physician Drug Samples’ Impact On Patient Safety Needs Study, IoM Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Institute of Medicine report on medication errors also recommends FDA issue guidances this year on packaging and drug naming.
You may also be interested in...
Sanofi-Aventis’ Insulin Pen Prone To Medication Errors – ISMP
OptiClik insulin delivery system’s digital display, when incorrectly oriented, may cause overdosing or subtherapeutic dosing, according to Medication Safety Alert.
Sanofi-Aventis’ Insulin Pen Prone To Medication Errors – ISMP
OptiClik insulin delivery system’s digital display, when incorrectly oriented, may cause overdosing or subtherapeutic dosing, according to Medication Safety Alert.
Exubera Labeling Could Trigger Dosing Errors, ISMP Says
Due to potential confusion between converting doses of inhaled insulin to units of injectable insulin, current labeling and dosing instructions should not have been approved, hazard alert says.